Financial results - BEBEPHARM SRL

Financial Summary - Bebepharm Srl
Unique identification code: 30545492
Registration number: J2014002034123
Nace: 4773
Sales - Ron
3.790.177
Net Profit - Ron
73.696
Employees
28
Open Account
Company Bebepharm Srl with Fiscal Code 30545492 recorded a turnover of 2024 of 3.790.177, with a net profit of 73.696 and having an average number of employees of 28. The company operates in the field of Comerţ cu amănuntul al produselor farmaceutice having the NACE code 4773.
Sales - Ron

Sales, Profit, Employees, Total Income, Financial Results - Bebepharm Srl

2015 2016 2017 2018 2019 2020 2021 2022 2023 2024
Sales - EUR 460.037 852.522 1.071.241 1.383.964 1.712.161 2.097.093 2.807.723 2.928.856 2.950.306 3.790.177
Total Income - EUR 460.310 852.532 1.074.204 1.404.084 1.715.457 2.099.462 2.830.331 2.932.362 2.960.411 3.803.511
Total Expenses - EUR 440.771 764.596 1.000.906 1.273.464 1.512.525 1.920.548 2.533.316 2.653.890 2.860.155 3.702.041
Gross Profit/Loss - EUR 19.539 87.936 73.298 130.620 202.932 178.914 297.015 278.472 100.256 101.470
Net Profit/Loss - EUR 16.316 73.879 59.730 108.792 167.986 152.358 254.411 224.312 82.456 73.696
Employees 0 0 13 13 19 21 26 25 28 28
The table presents the most important indicators of the company from the Profit and Loss Account for the last 10 years of activity as found at the Ministry of Finance. The data provides the evolution of the company during this period regarding the increases and possibly decreases recorded. In the last year of activity, the sales increased by 29.2%, from 2.950.306 euro in the year 2023, to 3.790.177 euro in 2024. The Net Profit decreased by -8.299 euro, from 82.456 euro in 2023, to 73.696 in the last year.
Sales - Ron
Net Profit - Ron
Employees

Check the financial reports for the company - Bebepharm Srl

Rating financiar

Financial Rating -
BEBEPHARM SRL

See the company's note based on the submitted financial data, relative to the industry of which it is a part.

Financial Rating
Limite de plata

Payment Limits -
Bebepharm Srl

See the company's payment capacity for situations in which you conclude contracts with payment terms.

Check Payment Limits
Probabilitate de insolventa

Prob. of insolvency -
Bebepharm Srl

It determines the risk of insolvency based on the submitted accounting balance.

Insolvency Probability
Rapoarte financiare

Financial Reports -
Bebepharm Srl

Check all the financial reports of the company and know the risks in collaboration with it.

Check Financial Reports
Financial Analysis Reports provide a clear and comprehensive view of a company's financial activity. In addition to presenting financial data, the reports analyze this data so that any user can understand whether the results are positive or less favorable. The Financial Rating provides an analysis based on the most important financial ratios, including liquidity, solvency, and profitability. Payment Limits represent the maximum amounts for which a company can offer goods or services on credit to its clients. The Probability of Insolvency presents the theoretical probability that a company may not be able to meet its financial obligations towards its creditors, i.e., suppliers and financial institutions.

Debts, Equity, Inventories, Receivables, Accounts, Assets - Bebepharm Srl - CUI 30545492

2015 2016 2017 2018 2019 2020 2021 2022 2023 2024
Fixed Assets 42.174 33.164 87.238 72.323 128.143 205.404 180.222 165.309 207.311 182.338
Current Assets 206.870 304.806 364.567 366.828 561.319 810.196 1.141.075 990.607 1.015.990 1.281.388
Inventories 85.085 172.183 248.382 222.176 392.560 468.752 595.827 527.250 511.900 660.469
Receivables 90.431 79.770 89.206 124.610 135.172 278.979 402.297 355.702 375.146 521.572
Cash 31.353 52.853 26.979 20.043 33.586 62.466 142.951 107.655 128.944 99.347
Shareholders Funds 22.022 54.932 113.733 108.844 274.780 421.929 663.345 400.361 336.920 220.920
Social Capital 45 45 44 43 42 41 40 41 40 40
Debts 207.216 283.039 318.801 330.307 414.682 593.672 657.951 755.556 886.381 1.242.806
Income in Advance 19.806 19.604 19.272 0 0 0 0 0 0 0
Exchange rate - RON 4.9743 4.9465 4.9315 4.9468 4.8371 4.7454 4.6535 4.5681 4.4908 4.445
Main CAEN "4773 - 4773"
CAEN Financial Year 4773
The table presents the company's Balance Sheet structure for the last 10 years. Current Assets recorded a value of 1.281.388 euro in 2024 which includes Inventories of 660.469 euro, Receivables of 521.572 euro and cash availability of 99.347 euro.
The company's Equity was valued at 220.920 euro, while total Liabilities amounted to 1.242.806 euro. Equity decreased by -114.117 euro, from 336.920 euro in 2023, to 220.920 in 2024.

Risk Reports Prices

Reviews - Bebepharm Srl

Comments - Bebepharm Srl

Similar services useful for checking companies and business development.

SellNet

Get the contact details for any company and get in touch with it.

Sectoral Studies

Knows the market and develops its own development strategies according to sectorial data.

Databases

Export in excel files the data of the companies selected according to the desired criteria.

Import - Export

Find importers and exporters according to the type of activity and the countries in which they carry it out.

Similar services represent services associated with companies that allow for a better analysis of clients and suppliers. Company Contacts help you get in touch with the desired companies. Sector Studies provide an overview of an industry, the most important competitors, and the geographical distribution of companies. Company Lists allow you to attract new clients, while Import-Export services give you access to companies engaged in such activities.